Competitors
Competitors describe Sonova Holding AG's market in their own filings and calls. These verified passages and visual pages show where their strategies meet, using source documents preserved in Sources.
Demant A/S (DEMANT)
The closest pure-play rival — the only competitor that mirrors Sonova across all three of hearing-aid manufacturing (Oticon, Bernafon, Philips), audiological retail and diagnostics. Demant fields its own AI-driven premium platform and is racing Sonova to consolidate hearing-care clinics.
Demant describes the KIND acquisition — its largest ever — taking it past 4,500 clinics globally and making it a leading hearing-aid retailer in Germany: the same vertical-integration-into-retail playbook Sonova runs with its AudioNova/GEERS arm.
Søren Nielsen, President and CEO: We proudly announced and finalised the acquisition of KIND, one of the world’s leading retailers of hearing aids. This – our largest-ever – expansion of our global network of hearing care clinics complements our long-term aspirations of helping more people with hearing loss through personalised care. […] The KIND acquisition makes Demant a leading retailer in Germany and will increase the Group’s revenue by almost 10%. Acquiring KIND is yet another strategic step for us to further consolidate and grow our Hearing Care business. […] Combined with Demant’s existing global clinic footprint, we now have more than 4,500 clinics globally.
p. 7 · Read in context →
Amplifon S.p.A. (AMP)
The world's largest hearing-care retailer, and both a channel Sonova sells through and a direct rival to Sonova's owned AudioNova retail arm. Amplifon's filings size the retail market Sonova's Audiological Care segment competes in and explicitly flag hearing-aid makers' vertical integration as a competitive threat.
Amplifon's stated retail footprint — over 10,100 locations, of which about 5,630 direct clinics, 1,210 franchised and 3,280 shop-in-shops — the distribution scale Sonova's owned-retail expansion competes against.
On December 31st, 2025, the Group operated over 10,100 locations organized under three regions – EMEA, Americas and APAC. […] Thanks to the capillarity of its distribution network, composed of around 5,630 direct clinics and 1,210 clinics in franchising, Amplifon is always close to those sufering from hearing loss, allowing everyone, even those with reduced mobility, to easily access quality audiological service. With around 3,280 shop-in-shops & corners located in third-party premises such as pharmacies, opticians and medical clinics, the Company is able to reach people with hearing loss also in rural areas or in areas that are not as densely populated
p. 22 · Read in context →
EssilorLuxottica (EL)
Entered hearing through Nuance Audio — hearing-enhancing glasses positioned as an OTC alternative to traditional hearing aids — backed by a retail network Sonova cannot match. It is a form-factor disruptor at the mild-loss, OTC end of the market. Exhibits are limited to its hearing/Nuance Audio material, not its core eyewear business.
EssilorLuxottica's CEO reports Nuance Audio hearing glasses reaching 15,000 stores across twelve markets in their first year — a distribution reach well beyond Sonova's audiology-clinic channel.
Francesco Milleri, Chairman and Chief Executive Officer: Smart eyewear is a powerful example of this convergence in action. Powered by iconic brands such as Ray-Ban and Oakley, AI-enabled glasses are creating a new paradigm that integrates vision care, connectivity and intelligent AI companions seamlessly into everyday life. […] We also launched Nuance Audio hearing-enhancing glasses, now available across 15,000 stores in twelve markets.
p. 5 · Read in context →
EssilorLuxottica describes Nuance Audio as the first FDA-cleared preset Software-as-a-Medical-Device hearing aid in the US, and says it is engaging 'traditional audiology practices' and optical customers — entering Sonova's regulated market and channels.
Paving the way for a disruptive new category in the med-tech space, Nuance Audio Hearing Aid Software is the first FDAcleared, preset Software as Medical Device (SaMD) in the US. […] leveraging its extensive retail network, while also engaging both traditional audiology practices and optical wholesale customers to make this technology accessible to consumers wherever possible.
p. 121 · Read in context →
Audientes A/S (AUDNTS)
A small Danish maker of self-fitting, low-cost OTC hearing aids and hearables aimed at underserved and emerging markets. It attacks the affordability and OTC flank that Sonova's premium Phonak/Unitron portfolio does not serve — a disruptor to watch rather than a scale competitor today.
Audientes' self-description as a maker of 'smart, self-fitting, and affordable' hearing aids with the hearing test built into the device — a low-cost, self-fitting model that bypasses the audiologist-fitted premium channel Sonova relies on.
Audientes A/S is a Danish hearing technology company dedicated to developing smart, self-fitting, and affordable hearing aids and advanced hearables. Our mission is to make high-quality solutions for hearing improvement and enhancement accessible to everyone who needs them globally. […] Ven is a self-fitting, binaural hearing aid designed for individuals with severe to profound hearing loss in one or both ears. Featuring an industry-standard hearing test built into the device and Bluetooth functionality, Ven delivers the audio quality of a high-end digital hearing aid combined with the versatility of a next-generation Bluetooth headset.
p. 3 · Read in context →
Audientes frames its opportunity as the affordability and access gap — targeting the '95% of unmet demand' in the MENA region and serving 'millions globally' across regulated and non-regulated (OTC) channels — the low end premium pricing leaves open.
Steen Thygesen, CEO: One of the key roles of our Indian subsidiary is to develop markets across the Middle East, Africa, and Asia, aligning with our mission to bring hearing solutions to underserved markets. […] They aim to focus on the 95% of unmet demand for hearing aids in the region, not only driving product distribution but also leading educational initiatives aimed at empowering individuals with hearing impairments - helping to close the hearing care gap. […] Today, Audientes have developed and had manufactured affordable, self-fitting hearing solutions for regulated and non-regulated markets, designed to improve the quality of life for millions globally.
p. 6 · Read in context →
More peer documents
DEMANT_annual_report_FY2024 — 208 pages · Prior-year annual report to trend Demant's market-size framing and strategy statements against the FY2025 exhibits used here. · Open →
EL_annual_report_FY2024 — 528 pages · First-year Nuance Audio disclosure to establish the launch timeline and how EL initially framed its move into hearing. · Open →
6758_annual_report_FY2025 — 230 pages · Sony's Form 20-F: the ET&S 'Sound' category (p.21, headphones and wireless speakers) and its ¥295.6bn/¥290.5bn/¥278.8bn segment sales (p.154) — the consumer-audio adjacency that underlies Sony's OTC/CRE hearing-aid push, though the report discloses no hearing-aid product itself. · Open →
AUDNTS_annual_report_FY2023 — 33 pages · Audientes' stated intent to move from a niche neckband product into the 'mainstream segment for hearing aids' and its India (1.4bn population) affordability thesis. · Open →